Immediate Impact
70 standout
Citing Papers
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Nanfeng Fan being referenced
A phase II study of efficacy and safety of RC48-ADC in patients with locally advanced or metastatic HER2-overexpressing gastric or gastroesophageal junction cancers.
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Nanfeng Fan | 148 | 108 | 74 | 21 | 231 | |
| Hao Liu | 202 | 97 | 81 | 19 | 265 | |
| Ignacio Tusquets | 109 | 128 | 42 | 16 | 248 | |
| Sejung Park | 141 | 147 | 111 | 22 | 251 | |
| Takashi Kijima | 127 | 147 | 80 | 17 | 278 | |
| Yusuke Shimodaira | 142 | 51 | 117 | 18 | 217 | |
| Xiaodong Zhang | 110 | 97 | 153 | 29 | 255 | |
| Andrea Celotti | 209 | 92 | 175 | 21 | 290 | |
| Ariel E. Birnbaum | 115 | 110 | 59 | 25 | 268 | |
| Irene Pecora | 92 | 125 | 68 | 22 | 196 | |
| Arinilda Campos Bragagnoli | 126 | 157 | 91 | 15 | 236 |
All Works
Loading papers...